Oneness Biotech Co., Ltd.
TWO: 4743.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Shuling Cheng
- Employees
- 180
- Headquarters
- Taipei, Taiwan
- IPO year
- 2011
- Market cap
- NT$24.7B
- Website
- https://www.onenessbio.com.tw
Loading 4743…
Loading profile data…Frequently asked questions about 4743
What does Oneness Biotech Co., Ltd. (4743.TWO) do?
Oneness Biotech Co., Ltd engages in the research and development of new drugs, and sale of pharmaceutical and health products in Taiwan. It operates through New Drug Research and Development, and Agricultural Products Cultivation segments. The company develops ON101, which is in Phase III clinical trials for treating chronic diabetic foot ulcers...
Where does 4743.TWO trade?
Oneness Biotech Co., Ltd. (4743.TWO) trades on the Taipei Exchange.
What sector is 4743.TWO in?
Oneness Biotech Co., Ltd. (4743.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Oneness Biotech Co., Ltd.?
Shuling Cheng is the chief executive officer of Oneness Biotech Co., Ltd. (4743.TWO).
Where is Oneness Biotech Co., Ltd. headquartered?
Oneness Biotech Co., Ltd. is headquartered in Taiwan.
Does 4743.TWO pay a dividend?
Oneness Biotech Co., Ltd. (4743.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4743.TWO go public?
Oneness Biotech Co., Ltd. (4743.TWO) completed its initial public offering in 2011.